Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies.

Autor: Ekholm, L.¹ Louise.ekholm@karolinska.se, Vosslamber, S.², Tjärnlund, A.¹, Jong, T. D.², Betteridge, Z.³, McHugh, N.³, Plestilova, L.⁴, Klein, M.⁴, Padyukov, L.¹, Voskuyl, A. E.⁵, Bultink, I. E. M.⁵, Pegtel, D. Michiel², Mavragani, C. P.^6,7, Crow, M. K.⁶, Vencovsky, J.⁴, Lundberg, I. E.¹, Verweij, C. L.^2,5

Publikováno v: Scandinavian Journal of Immunology. Aug2016, Vol. 84 Issue 2, p100-109. 10p.

THE TYPE I IFN SIGNATURE IN SORTED LEUKOCYTE SUBSETS FROM PERIPHERAL BLOOD OF RHEUMATOID ARTHRITIS PATIENTS; A MAJOR CONTRIBUTION BY GRANULOCYTES

Autor: de Jong, T. D., Lubbers, J., Turk, S., Vosslamber, S., Mantel, Elise, Bontkes, H. J., van der Laken, C. J., Bijlsma, J. W., van Schaardenburg, D., Verweij, C. L.

Publikováno v: Annals of the Rheumatic Diseases, 75(Suppl 1), A13-A13. BMJ Publishing Group
de Jong, T D, Lubbers, J, Turk, S, Vosslamber, S, Mantel, E, Bontkes, H J, van der Laken, C J, Bijlsma, J W, van Schaardenburg, D & Verweij, C L 2016, ' THE TYPE I IFN SIGNATURE IN SORTED LEUKOCYTE SUBSETS FROM PERIPHERAL BLOOD OF RHEUMATOID ARTHRITIS PATIENTS; A MAJOR CONTRIBUTION BY GRANULOCYTES ', Annals of the Rheumatic Diseases, vol. 75, no. Suppl 1, pp. A13-A13 . https://doi.org/10.1136/annrheumdis-2016-209124.31

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eea864a8a88f3f5f2e78b60b1ba87e0d
https://research.vumc.nl/en/publications/10bc0e1b-7ce3-4b72-9713-26676eb64858

The Type I Interferon System In Autoimmune Diseases:Molecular Markers For Heterogeneity And Therapy Response Prediction

Autor: Vosslamber, S.

Publikováno v: Vosslamber, S 2014, ' The Type I Interferon System In Autoimmune Diseases : Molecular Markers For Heterogeneity And Therapy Response Prediction ', PhD, Vrije Universiteit Amsterdam .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4612::cbf7a5ea07da832c63f13a27cdf8bb0e

Relevance of the Type I Interferon Signature in Multiple Sclerosis Towards a Personalized Medicine Approach for Interferon-beta Therapy

Autor: Verweij, C.L., Vosslamber, S.

Publikováno v: Discovery Medicine, 80, 51-60. Discovery Medicine
Verweij, C L & Vosslamber, S 2013, ' Relevance of the Type I Interferon Signature in Multiple Sclerosis Towards a Personalized Medicine Approach for Interferon-beta Therapy ', Discovery Medicine, vol. 80, pp. 51-60 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dab8a6d51359dc211022b3e3c290b9cb
https://research.vumc.nl/en/publications/b3818cea-192c-4ea3-b767-67fd6110ca16

Methotrexate Normalizes Up-Regulated Folate Pathway Genes in Rheumatoid Arthritis

Autor: Blits, M., Jansen, G., Assaraf, Y.G., van de Wiel, M., Lems, W.F., Nurmohamed, M.T., van Schaardenburg, D., Voskuyl, A.E., Wolbink, G.J., Vosslamber, S., Verweij, C.L.

Publikováno v: Blits, M, Jansen, G, Assaraf, Y G, van de Wiel, M, Lems, W F, Nurmohamed, M T, van Schaardenburg, D, Voskuyl, A E, Wolbink, G J, Vosslamber, S & Verweij, C L 2013, ' Methotrexate Normalizes Up-Regulated Folate Pathway Genes in Rheumatoid Arthritis ', Arthritis & Rheumatism, vol. 65, no. 11, pp. 2791-2802 . https://doi.org/10.1002/art.38094
Arthritis & Rheumatism, 65(11), 2791-2802. John Wiley and Sons Inc.

Objective The folate antagonist methotrexate (MTX) is an anchor drug in the treatment of rheumatoid arthritis (RA), but its mechanism of action with regard to the impact on folate metabolism remains elusive. The aim of the present study was to invest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::54e8672d0551f2e0dced14e9e47f79dd
https://hdl.handle.net/1871.1/0e3afc0d-0ff9-4a17-8cf7-a28e7184f5bb